Abhineet Kumar

Abbott India gets aggressive on new product launches, plans 110 in 5 years

The pharma firm, which had launched 14 products last year, is using social media to get into sub-therapies

Tata Trusts' direct holding in group firms to shrink to Rs 1.8 billion

Tata Sons' Chairman N Chandrasekaran has been vocal about simplifying cross holding within group firms since he took over last February

Abbott excels on power of brands, outpaces MNC peers on sales growth

The growth has come at a time when GST implementation affected most Indian pharma companies including Abbott's MNC peers

Aurobindo Pharma wrests second position among drug firms from Lupin

While Lupin recorded a 10.6 per cent decline in its sales for the period, the largest, Sun Pharma, recorded a 17.4 per cent fall

Ola cabs rank third among venture capital funding for Dec quarter

The top of the chart is occupied by Ola cabs' Chinese peer Didi Chuxing, China Internet Plus is second on the list

Pharma companies focus on limited competition drugs for the US market

Companies are sharing their strategy at JP Morgan Conference

Top 20 club: RIL has mountains to climb

The firm would require it to more than triple its CAGR of revenue to 18.5% for the next decade from 6%

Retailers go to small towns for big growth

Reliance Digital has established its presence in more than 100 cities and plans to expand further

Godrej Properties leads pack of outliers in real estate

In the Sept quarter, the Pirojsha Godrej-led firm recorded Rs 492 cr net sales, up 49% year-on-year

JSW Steel looks for partners in Bhushan Steel bid

Sources said JSW Steel was likely to bid 'aggressively' for Bhushan Steel

Tata Trusts focus on tech solutions

It comes after the success of the Aadhaar-enabled fertiliser distribution system in collaboration with the Andhra govt

We expect this quarter to have good uptick for our products: GSK Pharma MD

Q&A with Annaswamy Vaidheesh, MD of GSK Pharmaceuticals India

KKR eyes stressed assets with strategic partners

The business for distressed assets has almost been a non-starter in India

Leverage 'one Tata': Chandra to group CEOs

Chandra asked the companies to simplify their structure, become agile and cultivate accountability

Pharma sees investors cheering bonds, while stocks decline

Sun Pharma stock, the highest-valued Indian entity, dropped 13% to Rs 550

Temasek investments in India at $10 billion

It started investing outside Singapore in 2002-03

Taj turns the clock back on its brand

Indian Hotels rolls back its multi-brand strategy to focus solely on luxury

Our financial services biz will overtake pharma this year: Ajay Piramal

Interview with the chairman, Piramal Group & Shriram Group

Sloppy start to RERA as almost half the states are yet to notify rules

Almost half the states yet to notify rules, while others have watered down provisions of central Act

Can PSU insurers invest in tobacco companies? Bombay HC to decide

The New India Assurance Company also has a 1.7% stake in Hyderabad-based cigarette maker VST